Cargando…
STAT3/NF-κB-Regulated Lentiviral TK/GCV Suicide Gene Therapy for Cisplatin-Resistant Triple-Negative Breast Cancer
Triple-negative breast cancer (TNBC) represents approximately 20% of all breast cancers and appears resistance to conventional cytotoxic chemotherapy, demonstrating a particularly poor prognosis and a significantly worse clinical outcome than other types of cancer. Suicide gene therapy has been used...
Autores principales: | Kuo, Wei-Ying, Hwu, Luen, Wu, Chun-Yi, Lee, Jhih-Shian, Chang, Chi-Wei, Liu, Ren-Shyan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Ivyspring International Publisher
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5327640/ https://www.ncbi.nlm.nih.gov/pubmed/28255357 http://dx.doi.org/10.7150/thno.16827 |
Ejemplares similares
-
Gene Therapy with HSV1-sr39TK/GCV Exhibits a Stronger Therapeutic Efficacy Than HSV1-TK/GCV in Rat C6 Glioma Cells
por: Li, Lei-qing, et al.
Publicado: (2013) -
Efficacy of HSV-TK/GCV system suicide gene therapy using SHED expressing modified HSV-TK against lung cancer brain metastases
por: Oishi, Tomoya, et al.
Publicado: (2022) -
Synergistic effect of resveratrol and HSV-TK/GCV therapy on murine hepatoma cells
por: Xiao, Jianyong, et al.
Publicado: (2018) -
An experimental study on cervix cancer with combination of HSV-TK/GCV suicide gene therapy system and (60)Co radiotherapy
por: Chen, Daozhen, et al.
Publicado: (2010) -
Using HSV-TK/GCV suicide gene therapy to inhibit lens epithelial cell proliferation for treatment of posterior capsular opacification
por: Jiang, Yong-Xiang, et al.
Publicado: (2011)